👏 Congratulations to our collaborators on their recent publications
March 26, 2026
We are delighted to congratulate
EpiEndo Pharmaceuticals and the Institute of Pharmaceutical Science,
King's College London
on the publication of two exciting studies exploring the therapeutic potential of EP395:
📄 “The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung” published in "Lung"
📄 “Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation” published in "Pulmonary Pharmacology & Therapeutics"
These studies provide valuable insights into the role of EP395 in modulating inflammatory responses in respiratory disease, supporting its potential as a novel therapeutic approach.
At
Pharmidex, we are proud to have contributed to this work through our Respiratory Department, supporting the in vivo studies and helping advance these important findings.
We look forward to continuing our collaboration and supporting innovative programmes in respiratory drug discovery and development.
#RespiratoryResearch #DrugDiscovery #Inflammation #Preclinical #Collaboration #Pharmidex
We are pleased to share our latest publication: “Magnetic field-induced drug delivery from magnetic microporous nanocomposites through magnetic nanoparticles heating or motion” , published in the journal Materials & Design . This work explores innovative approaches to magnetically triggered drug delivery, leveraging the unique properties of magnetic nanoparticles to enable controlled release through heating and motion mechanisms. These advances have the potential to open new avenues in targeted therapies and precision medicine. We would like to sincerely thank our collaborators for their valuable contributions to this research: -CRCT Université de Toulouse Inserm U1037 CNR -Laboratoire de Physique et Chimie des Nano-Objets (LPCNO) CNRS-UPS-INSA -Centro Singular de Investigación en Química Biológica y Materiales Moleculares (CIQUS) We are proud to contribute to cutting-edge research at the interface of nanotechnology and drug delivery and we look forward to continuing collaborations that drive innovation in drug discovery and development. 🔗 Read the full article: https://www.sciencedirect.com/science/article/pii/S0264127526003084?via%3Dihub
Pharmidex is proud to be the Networking Sponsor at the Immuno-Oncology & Biomarker Summit in London. Over the next two days, the event provides an opportunity to discuss the latest advances in immuno-oncology, biomarker discovery, and precision medicine. If you’re attending, come and say hello to Ash Alavijeh to connect and explore opportunities to collaborate.
We’re excited to announce that Janette Dalay Robertson , Business Development Manager at Pharmidex , will be attending and exhibiting at the 10th RSC-BMCS Symposium on Mastering Medicinal Chemistry on Friday 13 March 2026 at Burlington House, London. Pharmidex is also proud to be sponsoring this fantastic event, which brings together leaders and innovators from across the medicinal chemistry community. If you’re attending, make sure to stop by and speak with Janette at the Pharmidex stand. She will be delighted to connect, discuss your research, and explore how Pharmidex can support your drug discovery and development programmes. 🤝 We look forward to meeting fellow scientists, collaborators, and partners at this exciting meeting.
